# Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/acquired-braf-v600e-mutation-as-resistant-mechanism-after-treatment-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Chao‐Chi Ho,Wei‐Yu Liao,Chih-An Lin,Jin‐Yuan Shih,Chong‐Jen Yu,James Chih‐Hsin Yang |
| Citations | 219 |
| DOI | 10.1016/j.jtho.2016.11.2231 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2559746652 |
| PMID | 27923714 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Chao‐Chi Ho](https://scholariq.org/researchers/chao-chi-ho/)
- [Chong‐Jen Yu](https://scholariq.org/researchers/chong-jen-yu/)
- [Jin‐Yuan Shih](https://scholariq.org/researchers/jin-yuan-shih/)
- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.